Senestech (NASDAQ:SNES) Issues Earnings Results, Misses Estimates By $0.05 EPS

Senestech (NASDAQ:SNES) posted its quarterly earnings results on Tuesday. The company reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.05), FiscalAI reports. The firm had revenue of $1.10 million for the quarter, compared to analyst estimates of $0.92 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%.

Senestech Stock Down 9.6%

SNES traded down $0.11 during trading on Tuesday, hitting $1.03. 39,760 shares of the company’s stock were exchanged, compared to its average volume of 364,641. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. The business’s 50 day moving average is $0.85 and its two-hundred day moving average is $1.46. Senestech has a fifty-two week low of $0.55 and a fifty-two week high of $3.40. The stock has a market cap of $5.58 million, a P/E ratio of -0.75 and a beta of 0.11.

Insider Buying and Selling at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management acquired 426,000 shares of the company’s stock in a transaction on Thursday, October 15th. The shares were purchased at an average cost of $0.77 per share, with a total value of $328,020.00. Following the completion of the purchase, the insider owned 1,505,294 shares of the company’s stock, valued at approximately $1,159,076.38. This represents a 39.47% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have acquired 1,123,679 shares of company stock valued at $814,836 over the last 90 days. 2.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research note on Wednesday, November 4th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Senestech Company Profile

SenesTech, Inc. is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management. SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.